Vigabatrin and Drowsiness - a phase IV clinical study of FDA data
Summary:
Drowsiness is reported as a side effect among people who take Vigabatrin (vigabatrin), especially for people who are female, 0-1 old, have been taking the drug for 1 - 6 months also take Epidiolex, and have Epilepsy.
The phase IV clinical study analyzes which people have Drowsiness when taking Vigabatrin. It is created by eHealthMe based on reports of 4,046 people who have side effects when taking Vigabatrin from the FDA, and is updated regularly.
What is Vigabatrin?
Vigabatrin has active ingredients of vigabatrin. eHealthMe is studying from 4,046 Vigabatrin users. Check the latest studies of Vigabatrin.
What is Drowsiness?
Drowsiness is found to be associated with 2,864 drugs and 4,800 conditions by eHealthMe. Check the latest studies of Drowsiness.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4,046 people reported to have side effects when taking Vigabatrin.
Among them, 149 people (3.68%) have Drowsiness.
Among these 149 people:
How long have people been on Vigabatrin when they have Drowsiness? *
What is the gender of people who have Drowsiness when taking Vigabatrin? *
What is the age of people who have Drowsiness when taking Vigabatrin? *
What are other drugs people take besides Vigabatrin? *
What are other side effects people have besides Drowsiness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Vigabatrin and have Drowsiness?
- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vigabatrin:
- Vigabatrin (4,046 reports)
Drowsiness treatments and more:
- Drowsiness (269,040 reports)
How severe was Drowsiness and when was it recovered:
Expand to all the drugs that have ingredients of vigabatrin:
- Drowsiness and drugs with ingredients of vigabatrin (674 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vigabatrin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Drowsiness:
- Drowsiness (2,864 drugs)
Browse all the conditions that are associated with Drowsiness:
- Drowsiness (4,800 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on vigabatrin (the active ingredients of Vigabatrin) and Vigabatrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Victoza cause Attention Deficit/Hyperactivity Disorder? - a second ago
- Could Victoza cause Attention Deficit Hyperactivity Disorder? - 2 seconds ago
- Could Lorazepam cause Extrapyramidal Disorder? - 5 seconds ago
- Could Bentyl cause International Normalised Ratio Increased? - 8 seconds ago
- Could Detrol cause Bone Marrow Failure? - 18 seconds ago
- Bactrim and Hepatic Encephalopathy for Men aged 50-59 - 20 seconds ago
- Bactrim and Hepatic Coma for Men aged 50-59 - 20 seconds ago
- Bactrim and Encephalopathy - Hepatic for Men aged 50-59 - 20 seconds ago
- Drug interactions of Vimovo and Ciprofloxacin - 33 seconds ago
- Could Coumadin cause Activated Partial Thromboplastin Time Prolonged? - 34 seconds ago